刊名:Journal of the European Academy of Dermatology and Venereology
出版年:2016
出版时间:July 2016
年:2016
卷:30
期:7
页码:1120-1124
全文大小:339K
ISSN:1468-3083
文摘
Intralesional methotrexate (MTX–il) has been used as neoadjuvant therapy for keratoacanthoma but has only been utilized in a few isolated cases of cutaneous squamous cell carcinoma as neoadjuvant therapy (cSCC).